LabStyle Innovations Reports 2015 Results
• FDA clearance announced on December 22nd • 61% increase in sequential quarterly shipments • Q4 2015 net loss … Read more
LabStyle Innovations to Launch Dario Blood Glucose Monitoring System in the U.S. in Q1 2016
Sales channels to include direct-to-consumer, e-commerce, third-party distributors Establishing North American headquarters and warehouse to serve U.S. and Canada CAESAREA, … Read more
LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
Smartphone-based blood glucose monitor with unique all-in-one design cleared for launch in the world’s largest diabetes market CAESAREA, Israel, December … Read more
Dario Diabetes Management Solution Garners Global Media Coverage
CAESAREA, Israel, December 16, 2015 /PRNewswire/ — LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today … Read more
Investment From Existing Shareholders and Private Investors
A LabStyle distributor participated in the investment CAESAREA, Israel, November 19, 2015 /PRNewswire/ — LabStyle Innovations Corp. (DRIO), developer of the … Read more